位置:首页 > 蛋白库 > BTD_HUMAN
BTD_HUMAN
ID   BTD_HUMAN               Reviewed;         543 AA.
AC   P43251; A6NHF2; B2R865; B4DFX1; B4DLJ9; B7Z7C9; F8W1Q3; Q96EM9;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   14-APR-2009, sequence version 2.
DT   03-AUG-2022, entry version 184.
DE   RecName: Full=Biotinidase {ECO:0000305};
DE            Short=Biotinase;
DE            EC=3.5.1.12 {ECO:0000305|PubMed:9099842, ECO:0000305|PubMed:9654207};
DE   Flags: Precursor;
GN   Name=BTD {ECO:0000312|HGNC:HGNC:1122};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Liver;
RX   PubMed=7509806; DOI=10.1016/s0021-9258(17)37409-4;
RA   Cole H., Reynolds T.R., Lockyer J.M., Buck G.A., Denson T., Spence J.E.,
RA   Hymes J., Wolf B.;
RT   "Human serum biotinidase. cDNA cloning, sequence, and characterization.";
RL   J. Biol. Chem. 269:6566-6570(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9530634; DOI=10.1007/s003359900760;
RA   Knight H.C., Reynolds T.R., Meyers G.A., Pomponio R.J., Buck G.A., Wolf B.;
RT   "Structure of the human biotinidase gene.";
RL   Mamm. Genome 9:327-330(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2; 3 AND 4).
RC   TISSUE=Amygdala, Pericardium, and Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-119; ASN-150; ASN-203; ASN-349
RP   AND ASN-402.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-119; ASN-150; ASN-349 AND
RP   ASN-402.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [9]
RP   GLYCOSYLATION AT ASN-150.
RX   PubMed=19139490; DOI=10.1074/mcp.m800504-mcp200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F., Zheng Z.B.,
RA   Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y., Zhang Y.K., Deng Y.L.,
RA   Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core fucosylated
RT   glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
RN   [10]
RP   VARIANT BTD DEFICIENCY CYS-538, CHARACTERIZATION OF VARIANT BTD DEFICIENCY
RP   CYS-538, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=9099842; DOI=10.1007/s004390050397;
RA   Pomponio R.J., Norrgard K.J., Hymes J., Reynolds T.R., Buck G.A.,
RA   Baumgartner R., Suormala T., Wolf B.;
RT   "Arg538 to Cys mutation in a CpG dinucleotide of the human biotinidase gene
RT   is the second most common cause of profound biotinidase deficiency in
RT   symptomatic children.";
RL   Hum. Genet. 99:506-512(1997).
RN   [11]
RP   VARIANTS BTD DEFICIENCY VAL-128; THR-171; TYR-228; ARG-323; HIS-444;
RP   ASP-451; HIS-456; MET-532 AND CYS-538, CHARACTERIZATION OF VARIANT BTD
RP   DEFICIENCY HIS-444, CATALYTIC ACTIVITY, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=9654207; DOI=10.1007/s004390050742;
RA   Swango K.L., Demirkol M., Huener G., Pronicka E., Sykut-Cegielska J.,
RA   Schulze A., Mayatepek E., Wolf B.;
RT   "Partial biotinidase deficiency is usually due to the D444H mutation in the
RT   biotinidase gene.";
RL   Hum. Genet. 102:571-575(1998).
RN   [12]
RP   VARIANTS BTD DEFICIENCY THR-171 AND HIS-444.
RX   PubMed=10206677;
RX   DOI=10.1002/(sici)1098-1004(1998)11:5<410::aid-humu10>3.0.co;2-8;
RA   Norrgard K.J., Pomponio R.J., Swango K.L., Hymes J., Reynolds T.,
RA   Buck G.A., Wolf B.;
RT   "Double mutation (A171T and D444H) is a common cause of profound
RT   biotinidase deficiency in children ascertained by newborn screening in the
RT   United States.";
RL   Hum. Mutat. 11:410-410(1998).
CC   -!- FUNCTION: Catalytic release of biotin from biocytin, the product of
CC       biotin-dependent carboxylases degradation. {ECO:0000305|PubMed:9099842,
CC       ECO:0000305|PubMed:9654207}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=biotin amide + H2O = biotin + NH4(+); Xref=Rhea:RHEA:13081,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:16615, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:57586; EC=3.5.1.12; Evidence={ECO:0000305|PubMed:9099842,
CC         ECO:0000305|PubMed:9654207};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:13082;
CC         Evidence={ECO:0000305|PubMed:9099842, ECO:0000305|PubMed:9654207};
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space
CC       {ECO:0000305|PubMed:9099842, ECO:0000305|PubMed:9654207}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P43251-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P43251-2; Sequence=VSP_054925;
CC       Name=3;
CC         IsoId=P43251-3; Sequence=VSP_054926;
CC       Name=4;
CC         IsoId=P43251-4; Sequence=VSP_055921;
CC   -!- DISEASE: Biotinidase deficiency (BTD deficiency) [MIM:253260]: A
CC       juvenile form of multiple carboxylase deficiency, an autosomal
CC       recessive disorder of biotin metabolism, characterized by ketoacidosis,
CC       hyperammonemia, excretion of abnormal organic acid metabolites, and
CC       dermatitis. Biotinidase deficiency is characterized by seizures,
CC       hypotonia, skin rash, alopecia, ataxia, hearing loss, and optic
CC       atrophy. If untreated, symptoms usually become progressively worse, and
CC       coma and death may occur. {ECO:0000269|PubMed:10206677,
CC       ECO:0000269|PubMed:9099842, ECO:0000269|PubMed:9654207}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the carbon-nitrogen hydrolase superfamily.
CC       BTD/VNN family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-21 is the initiator.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U03274; AAC04318.1; -; mRNA.
DR   EMBL; AF018631; AAC21679.1; -; Genomic_DNA.
DR   EMBL; AF018630; AAC21679.1; JOINED; Genomic_DNA.
DR   EMBL; AK294301; BAG57582.1; -; mRNA.
DR   EMBL; AK297033; BAG59561.1; -; mRNA.
DR   EMBL; AK301838; BAH13565.1; -; mRNA.
DR   EMBL; AK313252; BAG36062.1; -; mRNA.
DR   EMBL; AC027129; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471055; EAW64254.1; -; Genomic_DNA.
DR   EMBL; BC012099; AAH12099.1; -; mRNA.
DR   CCDS; CCDS2628.1; -. [P43251-4]
DR   CCDS; CCDS63563.1; -. [P43251-4]
DR   CCDS; CCDS63564.1; -. [P43251-4]
DR   CCDS; CCDS63565.1; -. [P43251-4]
DR   PIR; A54362; A54362.
DR   RefSeq; NP_000051.1; NM_000060.4.
DR   RefSeq; NP_001268652.1; NM_001281723.2. [P43251-4]
DR   RefSeq; NP_001268653.1; NM_001281724.2. [P43251-4]
DR   RefSeq; NP_001268654.1; NM_001281725.2. [P43251-4]
DR   RefSeq; NP_001310511.1; NM_001323582.1. [P43251-4]
DR   RefSeq; XP_011532343.1; XM_011534041.2. [P43251-4]
DR   RefSeq; XP_016862577.1; XM_017007088.1. [P43251-4]
DR   AlphaFoldDB; P43251; -.
DR   SMR; P43251; -.
DR   BioGRID; 107151; 27.
DR   IntAct; P43251; 8.
DR   STRING; 9606.ENSP00000400995; -.
DR   ChEMBL; CHEMBL4802066; -.
DR   GlyConnect; 1043; 15 N-Linked glycans (5 sites).
DR   GlyGen; P43251; 6 sites, 22 N-linked glycans (5 sites).
DR   iPTMnet; P43251; -.
DR   PhosphoSitePlus; P43251; -.
DR   BioMuta; BTD; -.
DR   DMDM; 226693503; -.
DR   CPTAC; CPTAC-655; -.
DR   CPTAC; non-CPTAC-2634; -.
DR   CPTAC; non-CPTAC-2635; -.
DR   EPD; P43251; -.
DR   jPOST; P43251; -.
DR   MassIVE; P43251; -.
DR   MaxQB; P43251; -.
DR   PaxDb; P43251; -.
DR   PeptideAtlas; P43251; -.
DR   PRIDE; P43251; -.
DR   ProteomicsDB; 1193; -.
DR   ProteomicsDB; 29669; -.
DR   ProteomicsDB; 4540; -.
DR   ProteomicsDB; 55605; -. [P43251-1]
DR   Antibodypedia; 26848; 227 antibodies from 28 providers.
DR   DNASU; 686; -.
DR   Ensembl; ENST00000303498.10; ENSP00000306477.6; ENSG00000169814.16. [P43251-4]
DR   Ensembl; ENST00000383778.5; ENSP00000373288.4; ENSG00000169814.16. [P43251-4]
DR   Ensembl; ENST00000427382.2; ENSP00000397113.2; ENSG00000169814.16. [P43251-4]
DR   Ensembl; ENST00000437172.6; ENSP00000400995.2; ENSG00000169814.16. [P43251-4]
DR   Ensembl; ENST00000449107.7; ENSP00000388212.2; ENSG00000169814.16. [P43251-4]
DR   Ensembl; ENST00000643237.3; ENSP00000495254.2; ENSG00000169814.16. [P43251-4]
DR   Ensembl; ENST00000646371.1; ENSP00000495866.1; ENSG00000169814.16. [P43251-4]
DR   Ensembl; ENST00000672065.1; ENSP00000500403.1; ENSG00000169814.16. [P43251-1]
DR   Ensembl; ENST00000672112.1; ENSP00000500193.1; ENSG00000169814.16. [P43251-2]
DR   GeneID; 686; -.
DR   KEGG; hsa:686; -.
DR   MANE-Select; ENST00000643237.3; ENSP00000495254.2; NM_001370658.1; NP_001357587.1. [P43251-4]
DR   UCSC; uc003cah.5; human. [P43251-1]
DR   CTD; 686; -.
DR   DisGeNET; 686; -.
DR   GeneCards; BTD; -.
DR   GeneReviews; BTD; -.
DR   HGNC; HGNC:1122; BTD.
DR   HPA; ENSG00000169814; Tissue enhanced (liver).
DR   MalaCards; BTD; -.
DR   MIM; 253260; phenotype.
DR   MIM; 609019; gene.
DR   neXtProt; NX_P43251; -.
DR   OpenTargets; ENSG00000169814; -.
DR   Orphanet; 79241; Biotinidase deficiency.
DR   PharmGKB; PA25443; -.
DR   VEuPathDB; HostDB:ENSG00000169814; -.
DR   eggNOG; KOG0806; Eukaryota.
DR   GeneTree; ENSGT00390000013823; -.
DR   HOGENOM; CLU_033209_0_0_1; -.
DR   InParanoid; P43251; -.
DR   OrthoDB; 1276751at2759; -.
DR   PhylomeDB; P43251; -.
DR   TreeFam; TF323645; -.
DR   BRENDA; 3.5.1.12; 2681.
DR   PathwayCommons; P43251; -.
DR   Reactome; R-HSA-196780; Biotin transport and metabolism.
DR   Reactome; R-HSA-3371598; Defective BTD causes biotidinase deficiency.
DR   SABIO-RK; P43251; -.
DR   SignaLink; P43251; -.
DR   BioGRID-ORCS; 686; 13 hits in 1081 CRISPR screens.
DR   ChiTaRS; BTD; human.
DR   GenomeRNAi; 686; -.
DR   Pharos; P43251; Tbio.
DR   PRO; PR:P43251; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; P43251; protein.
DR   Bgee; ENSG00000169814; Expressed in islet of Langerhans and 185 other tissues.
DR   ExpressionAtlas; P43251; baseline and differential.
DR   Genevisible; P43251; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0047708; F:biotinidase activity; TAS:Reactome.
DR   GO; GO:0006768; P:biotin metabolic process; IBA:GO_Central.
DR   GO; GO:0007417; P:central nervous system development; TAS:ProtInc.
DR   CDD; cd07567; biotinidase_like; 1.
DR   Gene3D; 3.60.110.10; -; 1.
DR   InterPro; IPR012101; Biotinidase-like_euk.
DR   InterPro; IPR040154; Biotinidase/VNN.
DR   InterPro; IPR003010; C-N_Hydrolase.
DR   InterPro; IPR036526; C-N_Hydrolase_sf.
DR   InterPro; IPR043957; Vanin_C.
DR   PANTHER; PTHR10609; PTHR10609; 1.
DR   Pfam; PF00795; CN_hydrolase; 1.
DR   Pfam; PF19018; Vanin_C; 1.
DR   PIRSF; PIRSF011861; Biotinidase; 1.
DR   SUPFAM; SSF56317; SSF56317; 1.
DR   PROSITE; PS50263; CN_HYDROLASE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Direct protein sequencing; Disease variant;
KW   Glycoprotein; Hydrolase; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..41
FT   CHAIN           42..543
FT                   /note="Biotinidase"
FT                   /id="PRO_0000019707"
FT   DOMAIN          72..351
FT                   /note="CN hydrolase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00054"
FT   ACT_SITE        112
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00054"
FT   ACT_SITE        212
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00054"
FT   ACT_SITE        245
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00054"
FT   CARBOHYD        119
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952,
FT                   ECO:0000269|PubMed:19159218"
FT   CARBOHYD        150
FT                   /note="N-linked (GlcNAc...) (complex) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952,
FT                   ECO:0000269|PubMed:19139490, ECO:0000269|PubMed:19159218"
FT   CARBOHYD        203
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        349
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952,
FT                   ECO:0000269|PubMed:19159218"
FT   CARBOHYD        402
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952,
FT                   ECO:0000269|PubMed:19159218"
FT   CARBOHYD        489
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..20
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055921"
FT   VAR_SEQ         1..14
FT                   /note="MAHAHIQGGRRAKS -> MARKETQLIIKMNHLA (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054925"
FT   VAR_SEQ         1..13
FT                   /note="MAHAHIQGGRRAK -> MPEGGGTSRRLLPMQ (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054926"
FT   VARIANT         128
FT                   /note="F -> V (in BTD deficiency; dbSNP:rs397514355)"
FT                   /evidence="ECO:0000269|PubMed:9654207"
FT                   /id="VAR_005113"
FT   VARIANT         171
FT                   /note="A -> T (in BTD deficiency; dbSNP:rs13073139)"
FT                   /evidence="ECO:0000269|PubMed:10206677,
FT                   ECO:0000269|PubMed:9654207"
FT                   /id="VAR_005114"
FT   VARIANT         228
FT                   /note="D -> Y (in BTD deficiency; dbSNP:rs397514380)"
FT                   /evidence="ECO:0000269|PubMed:9654207"
FT                   /id="VAR_005115"
FT   VARIANT         323
FT                   /note="H -> R (in BTD deficiency; partial;
FT                   dbSNP:rs397507176)"
FT                   /evidence="ECO:0000269|PubMed:9654207"
FT                   /id="VAR_005116"
FT   VARIANT         391
FT                   /note="P -> S (in dbSNP:rs35034250)"
FT                   /id="VAR_056238"
FT   VARIANT         444
FT                   /note="D -> H (in BTD deficiency; profound and partial; 52%
FT                   decrease in biotinyl-transferase activity;
FT                   dbSNP:rs13078881)"
FT                   /evidence="ECO:0000269|PubMed:10206677,
FT                   ECO:0000269|PubMed:9654207"
FT                   /id="VAR_005117"
FT   VARIANT         451
FT                   /note="G -> D (in BTD deficiency; partial;
FT                   dbSNP:rs397514419)"
FT                   /evidence="ECO:0000269|PubMed:9654207"
FT                   /id="VAR_005118"
FT   VARIANT         456
FT                   /note="Q -> H (in BTD deficiency; dbSNP:rs80338685)"
FT                   /evidence="ECO:0000269|PubMed:9654207"
FT                   /id="VAR_005119"
FT   VARIANT         532
FT                   /note="T -> M (in BTD deficiency; dbSNP:rs104893688)"
FT                   /evidence="ECO:0000269|PubMed:9654207"
FT                   /id="VAR_005120"
FT   VARIANT         538
FT                   /note="R -> C (in BTD deficiency; not detectable protein
FT                   levels; loss of biotinyl-transferase activity;
FT                   dbSNP:rs80338686)"
FT                   /evidence="ECO:0000269|PubMed:9099842,
FT                   ECO:0000269|PubMed:9654207"
FT                   /id="VAR_005121"
FT   CONFLICT        379
FT                   /note="H -> Y (in Ref. 3; BAH13565)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   543 AA;  61133 MW;  1A999893A0784944 CRC64;
     MAHAHIQGGR RAKSRFVVCI MSGARSKLAL FLCGCYVVAL GAHTGEESVA DHHEAEYYVA
     AVYEHPSILS LNPLALISRQ EALELMNQNL DIYEQQVMTA AQKDVQIIVF PEDGIHGFNF
     TRTSIYPFLD FMPSPQVVRW NPCLEPHRFN DTEVLQRLSC MAIRGDMFLV ANLGTKEPCH
     SSDPRCPKDG RYQFNTNVVF SNNGTLVDRY RKHNLYFEAA FDVPLKVDLI TFDTPFAGRF
     GIFTCFDILF FDPAIRVLRD YKVKHVVYPT AWMNQLPLLA AIEIQKAFAV AFGINVLAAN
     VHHPVLGMTG SGIHTPLESF WYHDMENPKS HLIIAQVAKN PVGLIGAENA TGETDPSHSK
     FLKILSGDPY CEKDAQEVHC DEATKWNVNA PPTFHSEMMY DNFTLVPVWG KEGYLHVCSN
     GLCCYLLYER PTLSKELYAL GVFDGLHTVH GTYYIQVCAL VRCGGLGFDT CGQEITEATG
     IFEFHLWGNF STSYIFPLFL TSGMTLEVPD QLGWENDHYF LRKSRLSSGL VTAALYGRLY
     ERD
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024